Sonoma Pharmaceuticals, Inc. announced that in connection with the Woodstock office closure, Mr. Jerry Dvonch resigned as Chief Financial Officer. Mr. Dvonch has agreed to assist with transitioning the Company's operations to the Boulder office on or before December 31, 2022.